Our study showed that p53 is crucial for ACP52C‐mediated apoptosis induction in cancer cells with wildtype or R280K‐mutated p53, as p53 KD, specifically targeting residues 231–236 of p53, leading to a three to fourfold increase in GI50 (Figure 6B). This evidence concerns the gene TP53 and cancer.